When we open a laboratory report, many of us are looking for one answer:
Am I safe?
We scan for “normal,” hoping it means we are protected from heart disease, stroke, or diabetes. If a result is marked high or low, we expect that number to explain what is wrong and what to do next.
But neither label tells the whole story.
Routine laboratory testing is valuable, yet a result within range does not guarantee freedom from disease or future risk. Laboratory reference ranges and cardiovascular treatment targets are not always the same. The meaning of a result depends on the person’s medical history, family history,y and overall risk.
An abnormal result also deserves context. It may identify a concern without fully explaining its drivers or which additional steps could help reduce risk. Established treatment should begin when indicated; selected advanced testing may help refine the plan.
At Smile More Longevity Campus, we believe patients deserve understanding and action. Boston Heart Diagnostics helps connect laboratory findings with a more individualized prevention conversation.
Looking Beyond Routine Cholesterol
A traditional lipid panel reports total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. These measurements remain essential, but people with similar results can have different cardiovascular risks.
Boston Heart offers additional tests that may help clarify those differences. Apolipoprotein B, or apoB, reflects the number of particles associated with plaque formation. Lipoprotein(a), or Lp(a), is a predominantly inherited cardiovascular risk factor that is not included in most routine lipid panels. Selected panels also assess small dense LDL, inflammation,n and metabolic markers involving glucose and insulin.
For example, someone with reassuring routine cholesterol results may still have elevated Lp(a). Someone already treating high cholesterol may have additional risk factors that deserve attention. Neither person’s risk can be understood from one number alone.
Boston Heart’s Cholesterol Balance test measures markers associated with cholesterol production and absorption. In appropriate patients, these findings may add context to discussions about treatment response. They complement clinical assessment rather than independently determining which diet or medication someone needs.
The value lies in choosing information that can inform a decision, then following through.
Genetics Adds Another Perspective
Genetic testing can reveal inherited susceptibility that may not be apparent in today’s laboratory results. Boston Heart offers selected genetic tests, including polygenic risk assessments that examine the combined influence of many genetic variations.
Depending on the test, these assessments may provide information about susceptibility to coronary artery disease, stroke, atrial fibrillation, hypertension, or type 2 diabetes.
This can add perspective for someone with a strong family history or help frame prevention before disease develops. However, genetic risk scores have limitations, including differences in accuracy across populations. They do not diagnose disease or guarantee that it will occur.
A higher genetic risk can prompt a more focused discussion about established preventive measures, monitoring, and specialist evaluation. A lower score does not erase other risks. Testing should be selected thoughtfully, with informed consent and professional interpretation.
From Findings to Follow-Through
Advanced testing cannot certify that someone is safe. Its purpose is to help clarify risk and support meaningful decisions.
A useful plan identifies priorities, explains recommended actions, and establishes when progress will be reviewed. That may involve nutrition, physical activity, blood pressure management, tobacco avoidance, sleep, weight management, or medication when medically indicated.
At Smile More Longevity Campus, we connect education with support and appropriate medical collaboration. Follow-up helps patients understand whether their plan is improving measures and whether adjustments are needed.
Your Mouth Belongs in the Conversation
After nearly 30 years in dentistry, I know oral health deserves a place in broader health discussions. Periodontal disease, diabetes,s and cardiovascular disease share risk factors and inflammatory connections.
Research supports an association between periodontal disease and cardiovascular disease. It does not establish that treating gum disease prevents heart attacks or strokes. Dental care remains valuable for its proven oral-health benefits and belongs alongside medical prevention.
Petaluma Dental Group brings attention to periodontal health, breathing, and sleep concerns. Allume MedSpa extends campus support through medically guided wellness and weight management, with Boston Heart testing adding selected insights into cardiovascular and metabolic risk.
Ask the Allume team whether a medical consultation and Boston Heart testing may be appropriate for you. Ask your PDG provider how oral health fits into your broader health picture.
We all want reassurance. A more useful foundation is understanding our risks and taking consistent action.
That is the purpose behind Smile More. Live Longer.™
About Smile More Longevity Campus™
Smile More Longevity Campus™ in Petaluma brings together Petaluma Dental Group, Smile More Orthodontics, Allume MedSpa, and Luminary Education Center, connecting oral health, confident smiles, whole-body wellness, and professional education. Each offers distinct services with a shared commitment to prevention, healthy aging, and informed choices.
Smile More. Live Longer.™
Any content, resident submissions, guest columns, advertisements, and advertorials are not necessarily endorsed by or represent the views of Best Version Media LLC (BVM) or any municipality, homeowners associations, businesses, or organizations that this publication serves. BVM is not responsible for the reliability, suitability, or timeliness of any content submitted, inclusive of materials generated or composed through artificial intelligence (AI). All content submitted is done so at the sole discretion of the submitting party.
